Albany Molecular Research, Inc. (NASDAQ:AMRI)

CAPS Rating: 4 out of 5

The Company is a global chemistry-based drug discovery and development company focused on identifying and developing novel biologically active small molecules with applications in the drug market.

Recs

0
Player Avatar NWTOGME (< 20) Submitted: 10/4/2008 3:19:52 PM : Outperform Start Price: $14.21 AMRI Score: -107.09

L/R D/E ratio's look good.

Featured Broker Partners


Advertisement